MHE State of the Industry survey: The COVID-19 vaccine
In this second of a six-part series, the biggest concern is short supply.
The State of the Industry survey was conducted in October and November before the FDA granted emergency use authorizations for the Pfizer-BioNTech and the Moderna vaccines. Roughly one-third (32%) of the respondents indicated that they were extremely concerned about the vaccine being in short supply, and 41% were indicated that level of concern about a large percentage of American not getting vaccinated.
Articles in this issue
MHE State of the Industry survey: Healthcare disparities and racism
MHE State of the Industry survey: The shift to value-based care
MHE State of the Industry survey: The pandemic’s effects
MHE State of the Industry survey: Grading the Trump Administration COVID-19 response
MHE State of the Industry survey: The COVID-19 vaccine
MHE State of the Industry survey: COVID-19 ranks No.1
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
